Cilostazol for Prevention of Recurrent Stroke Trial
Stanford University
Summary
The goal of this clinical trial is to learn whether adding cilostazol to aspirin or clopidogrel prevents stroke and heart attack in people who have had a stroke or mini-stroke.
Eligibility
- Age range
- 40+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Diagnosis of stroke or mini-stroke (also called TIA) within the last 180 days * Currently taking aspirin or clopidogrel (not both) to prevent another stroke Exclusion Criteria: * Had a spontaneous brain bleed within the last 2 years. * Moderate to severe heart failure. * Life expectancy is less than 6 months.
Interventions
- DrugCilostazol 100 mg
Cilostazol 100 mg tablet taken orally twice daily following an initial 2-week period during which cilostazol is dosed at 100 mg tablet taken orally once daily to maximize tolerability.
- DrugPlacebo
Placebo 100 mg tablet twice taken orally daily following an initial 2-week period during which placebo is dosed at 100 mg taken orally once daily to maximize tolerability.
Location
- Stanford UniversityStanford, California